Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | FTO | Q9C0B1 | 4/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1638350 | 0.89 | CYP3A4 (0.48) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL1638523 | 0.86 | CYP3A4 (0.53) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL1208665 | 0.84 | FTO (0.51) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL1638515 | 0.82 | FTO (0.51) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL25759008 | 0.81 | CYP3A4 (0.77) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL3295066 | 0.81 | FTO (0.56) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL10521293 | 0.80 | FTO (0.59) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL1639993 | 0.80 | FTO (0.47) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL6411749 | 0.79 | FTO (0.57) | CYP3A4MAPTMEN1KMT2AFTO | |
| SCHEMBL1207502 | 0.78 | FTO (0.71) | CYP3A4MAPTMEN1KMT2AFTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098487-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. | 2011-04-28 | — | — | US | disclosed |
| US-7807607-B2 | Color-forming compounds and use thereof in imaging members and methods | ZINK IMAGING, INC. (US) | 2010-10-05 | — | — | US | disclosed |
| WO-2010075544-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. (US) | 2010-07-01 | — | — | WO | disclosed |
| US-20090137389-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098487-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | HCCS, RB1, CACYBP | CYP3A4 1426/4885MAPT 520/4885MEN1 2050/4885 |
| US-20090137389-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | HCCS, RB1, CACYBP | CYP3A4 1426/4885MAPT 520/4885MEN1 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.